TREM2 regulates purinergic receptor-mediated calcium signaling and motility in human iPSC-derived microglia
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
The membrane protein TREM2 (Triggering Receptor Expressed on Myeloid cells 2) regulates key microglial functions including phagocytosis and chemotaxis. Loss-of-function variants of TREM2 are associated with increased risk of Alzheimer’s disease (AD). Because abnormalities in Ca 2+ signaling have been observed in several AD models, we investigated TREM2 regulation of Ca 2+ signaling in human induced pluripotent stem cell-derived microglia (iPSC-microglia) with genetic deletion of TREM2. We found that iPSC-microglia lacking TREM2 (TREM2 KO) show exaggerated Ca 2+ signals in response to purinergic agonists, such as ADP, that shape microglial injury responses. This ADP hypersensitivity, driven by increased expression of P2Y 12 and P2Y 13 receptors, results in greater release of Ca 2+ from the endoplasmic reticulum stores, which triggers sustained Ca 2+ influx through Orai channels and alters cell motility in TREM2 KO microglia. Using iPSC-microglia expressing the genetically encoded Ca 2+ probe, Salsa6f, we found that cytosolic Ca 2+ tunes motility to a greater extent in TREM2 KO microglia. Despite showing greater overall displacement, TREM2 KO microglia exhibit reduced directional chemotaxis along ADP gradients. Accordingly, the chemotactic defect in TREM2 KO microglia was rescued by reducing cytosolic Ca 2+ using a P2Y 12 receptor antagonist. Our results show that loss of TREM2 confers a defect in microglial Ca 2+ response to purinergic signals, suggesting a window of Ca 2+ signaling for optimal microglial motility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro
Liang, C.-C., Park, A. Y., & Guan, J.-L. (2007) · Nature Protocols · doi:10.1038/nprot.2007.30 · Cited by 4,696 · cited 1×
“Because no chemical gradient is formed in the scratch wound assay ( Liang et al., 2007 ), we studied microglial tracks overlain (left).”
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979 · cited 8×
“In response to neurodegenerative disease, microglia downregulate P2Y 12 receptors ( Krasemann et al., 2017 ; Sala Frigerio et al., 2019 ; Lou et al., 2016 ).”
InfluentialJansen, I. E., Savage, J. E., Watanabe, K., Bryois, J., Williams, D. M., Steinberg, S., Sealock, J., Karlsson, I. K., Hägg, S., Athanasiu, L., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0311-9 · Cited by 2,277 · cited 1×
“…implicated in several neurodevelopmental and neurodegenerative diseases ( Andersen et al., 2021 ; Crotti et al., 2014 ; Fahira et al., 2019 ; Jansen et al., 2019 ; McQuade and Blurton-Jones, 2019 ; Pimenova et al., 2021 ; Tan et al., 2013 ), warranting further study of human microglial…”
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542 · cited 4×
“…brain constitute key signals driving microglial activation and chemotaxis, and are detected by microglial cells over concentrations ranging from hundreds of nM to μM ( Davalos et al., 2005 ; De Simone et al., 2010 ; Honda et al., 2001 ; Koizumi et al., 2007 ; Haynes et al., 2006 ; Yegutkin, 2008 ).”
InfluentialiPSC-derived human microglia-like cells to study neurological diseases
Abud, E. M., Ramirez, R. N., Martinez, E. S., Healy, L. M., Nguyen, C. H. H., Newman, S. A., Yeromin, A. V., Scarfone, V. M., Marsh, S. E., Fimbres, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.042 · Cited by 1,154 · cited 3×
“…between WT and TREM2 KO cells ( Figure 3G ), as further substantiated by similar transcriptomic expression of IP 3 receptor type 2 (the major IP 3 R subtype expressed in iPSC-microglia) in WT and TREM2 KO cells ( Figure 2—figure supplement 1C and D ; McQuade et al., 2020 ; Abud et al., 2017 ).”
Self-citationSala Frigerio, C., Wolfs, L., Fattorelli, N., Thrupp, N., Voytyuk, I., Schmidt, I., Mancuso, R., Chen, W.-T., Woodbury, M. E., Srivastava, G., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.099 · Cited by 926
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis
Koizumi, S., Shigemoto-Mogami, Y., Nasu-Tada, K., Shinozaki, Y., Ohsawa, K., Tsuda, M., Joshi, B. V., Jacobson, K. A., Kohsaka, S., & Inoue, K. (2007) · Nature · doi:10.1038/nature05704 · Cited by 802
Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease
Olah, M., Menon, V., Habib, N., Taga, M. F., Ma, Y., Yung, C. J., Cimpean, M., Khairallah, A., Coronas-Samano, G., Sankowski, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19737-2 · Cited by 722
SuperPlots: Communicating reproducibility and variability in cell biology
Lord, S. J., Velle, K. B., Mullins, R. D., & Fritz-Laylin, L. K. (2020) · Journal of Cell Biology · doi:10.1083/jcb.202001064 · Cited by 718 · cited 1×
“Data are reported as superplots ( Lord et al., 2020 ) of at least three independent replicates.”
Microglia monitor and protect neuronal function through specialized somatic purinergic junctions
Cserép, C., Pósfai, B., Lénárt, N., Fekete, R., László, Z. I., Lele, Z., Orsolits, B., Molnár, G., Heindl, S., Schwarcz, A. D., et al. (2020) · Science · doi:10.1126/science.aax6752 · Cited by 684 · cited 2×
“…to cortical injury ( Haynes et al., 2006 ; Cserép et al., 2020 ), NLRP3 inflammasome activation ( Suzuki et al., 2020 ; Wu et al., 2019 ), neuronal hyperactivity and protection ( Cserép et al., 2020 ; Eyo et al., 2014 ), and blood-brain barrier maintenance ( Lou et al., 2016 ; Bisht et al., 2021 ).”
A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer’s disease
Park, J., Wetzel, I., Marriott, I., Dréau, D., D’Avanzo, C., Kim, D. Y., Tanzi, R. E., & Cho, H. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0175-4 · Cited by 644
Self-citationExtracellular ATP or ADP Induce Chemotaxis of Cultured Microglia through Gi/o-Coupled P2Y Receptors
Honda, S., Sasaki, Y., Ohsawa, K., Imai, Y., Nakamura, Y., Inoue, K., & Kohsaka, S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01975.2001 · Cited by 561
Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
Parhizkar, S., Arzberger, T., Brendel, M., Kleinberger, G., Deussing, M., Focke, C., Nuscher, B., Xiong, M., Ghasemigharagoz, A., Katzmarski, N., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0296-9 · Cited by 555
Wang, S., Mustafa, M., Yuede, C. M., Salazar, S. V., Kong, P., Long, H., Ward, M., Siddiqui, O., Paul, R., Gilfillan, S., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200785 · Cited by 549
Eyo, U. B., Peng, J., Swiatkowski, P., Mukherjee, A., Bispo, A., & Wu, L.-J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0416-14.2014 · Cited by 509
McQuade, A., Coburn, M., Tu, C. H., Hasselmann, J., Davtyan, H., & Blurton-Jones, M. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0297-x · Cited by 449
Self-citationDevelopment of a Chimeric Model to Study and Manipulate Human Microglia In Vivo
Hasselmann, J., Coburn, M. A., England, W., Figueroa Velez, D. X., Kiani Shabestari, S., Tu, C. H., McQuade, A., Kolahdouzan, M., Echeverria, K., Claes, C., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.07.002 · Cited by 380 · cited 3×
“…to microglial communication with other brain cell types and has been negatively correlated with the onset of disease-associated microglia (DAM) transcriptional states ( Hasselmann et al., 2019 ; Keren-Shaul et al., 2017 ; Krasemann et al., 2017 ; Olah et al., 2020 ; Sala Frigerio et al., 2019 ).”
Self-citationTREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease
Griciuc, A., Patel, S., Federico, A. N., Choi, S. H., Innes, B. J., Oram, M. K., Cereghetti, G., McGinty, D., Anselmo, A., Sadreyev, R. I., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.06.010 · Cited by 378
Purinergic receptor P2RY12-dependent microglial closure of the injured blood–brain barrier
Lou, N., Takano, T., Pei, Y., Xavier, A. L., Goldman, S. A., & Nedergaard, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520398113 · Cited by 364 · cited 2×
“…to cortical injury ( Haynes et al., 2006 ; Cserép et al., 2020 ), NLRP3 inflammasome activation ( Suzuki et al., 2020 ; Wu et al., 2019 ), neuronal hyperactivity and protection ( Cserép et al., 2020 ; Eyo et al., 2014 ), and blood-brain barrier maintenance ( Lou et al., 2016 ; Bisht et al., 2021 ).”
McQuade, A., Kang, Y. J., Hasselmann, J., Jairaman, A., Sotelo, A., Coburn, M., Shabestari, S. K., Chadarevian, J. P., Fote, G., Tu, C. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19227-5 · Cited by 361
Self-citationMutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors
Crotti, A., Benner, C., Kerman, B. E., Gosselin, D., Lagier-Tourenne, C., Zuccato, C., Cattaneo, E., Gage, F. H., Cleveland, D. W., & Glass, C. K. (2014) · Nature Neuroscience · doi:10.1038/nn.3668 · Cited by 333 · cited 1×
“Microglia are strongly implicated in several neurodevelopmental and neurodegenerative diseases ( Andersen et al., 2021 ; Crotti et al., 2014 ; Fahira et al., 2019 ; Jansen et al., 2019 ; McQuade and Blurton-Jones, 2019 ; Pimenova et al., 2021 ; Tan et al., 2013 ), warranting further study of human…”
Expression of Novel Alzheimer’s Disease Risk Genes in Control and Alzheimer’s Disease Brains
Karch, C. M., Jeng, A. T., Nowotny, P., Cady, J., Cruchaga, C., & Goate, A. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050976 · Cited by 328 · cited 1×
“Loss of TREM2 function is thought to promote a more homeostatic-like state ( Krasemann et al., 2017 ; Andrews et al., 2020 ; Karch et al., 2012 ).”
Interpretation of risk loci from genome-wide association studies of Alzheimer's disease
Andrews, S. J., Fulton-Howard, B., & Goate, A. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30435-1 · Cited by 314 · cited 1×
“Loss of TREM2 function is thought to promote a more homeostatic-like state ( Krasemann et al., 2017 ; Andrews et al., 2020 ; Karch et al., 2012 ).”
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
Ulrich, J. D., Finn, M. B., Wang, Y., Shen, A., Mahan, T. E., Jiang, H., Stewart, F. R., Piccio, L., Colonna, M., & Holtzman, D. M. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-20 · Cited by 302 · cited 1×
“Upon ligand binding, TREM2 signals through its adaptor protein DAP12 to activate a host of downstream pathways ( Krasemann et al., 2017 ; Cheng-Hathaway et al., 2018 ; McQuade et al., 2020 ; Ulrich et al., 2014 ).”
Activation of Neuronal NMDA Receptors Triggers Transient ATP-Mediated Microglial Process Outgrowth
Dissing-Olesen, L., LeDue, J. M., Rungta, R. L., Hefendehl, J. K., Choi, H. B., & MacVicar, B. A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0405-14.2014 · Cited by 286
Morrison, H., Young, K., Qureshi, M., Rowe, R. K., & Lifshitz, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-13581-z · Cited by 276 · cited 1×
“The basic workflow for microglia process analysis was adapted from Morrison et al., 2017 .”
The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease
Cheng-Hathaway, P. J., Reed-Geaghan, E. G., Jay, T. R., Casali, B. T., Bemiller, S. M., Puntambekar, S. S., von Saucken, V. E., Williams, R. Y., Karlo, J. C., Moutinho, M., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0262-8 · Cited by 252 · cited 3×
“This assay revealed a deficit of chemotaxis in TREM2 KO microglia ( Figure 7A ), mirroring reports that TREM2 KO microglia are unable to migrate toward amyloid plaques in AD ( Cheng-Hathaway et al., 2018 ; McQuade et al., 2020 ; Meilandt et al., 2020 ).”
Impact of TREM2R47H variant on tau pathology–induced gliosis and neurodegeneration
Gratuze, M., Leyns, C. E. G., Sauerbeck, A. D., St-Pierre, M.-K., Xiong, M., Kim, N., Serrano, J. R., Tremblay, M.-È., Kummer, T. T., Colonna, M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138179 · Cited by 252
Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk
McQuade, A., & Blurton-Jones, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.045 · Cited by 244 · cited 1×
“…implicated in several neurodevelopmental and neurodegenerative diseases ( Andersen et al., 2021 ; Crotti et al., 2014 ; Fahira et al., 2019 ; Jansen et al., 2019 ; McQuade and Blurton-Jones, 2019 ; Pimenova et al., 2021 ; Tan et al., 2013 ), warranting further study of human microglial dynamics.”
Self-citationAndreone, B. J., Przybyla, L., Llapashtica, C., Rana, A., Davis, S. S., van Lengerich, B., Lin, K., Shi, J., Mei, Y., Astarita, G., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0650-6 · Cited by 233 · cited 1×
“While iPSC-microglia are proving increasingly useful to investigate neurodegenerative disorders ( McQuade et al., 2020 ; Andreone et al., 2020 ; Cosker et al., 2021 ; Konttinen et al., 2019 ; Piers et al., 2020 ; You et al., 2022 ), Ca 2+ signaling has not yet been extensively profiled in these…”
Meilandt, W. J., Ngu, H., Gogineni, A., Lalehzadeh, G., Lee, S.-H., Srinivasan, K., Imperio, J., Wu, T., Weber, M., Kruse, A. J., et al. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.1871-19.2019 · Cited by 210
PSEN1ΔE9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia
Konttinen, H., Cabral-da-Silva, M. E. C., Ohtonen, S., Wojciechowski, S., Shakirzyanova, A., Caligola, S., Giugno, R., Ishchenko, Y., Hernández, D., Fazaludeen, M. F., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.08.004 · Cited by 191 · cited 1×
“…iPSC-microglia are proving increasingly useful to investigate neurodegenerative disorders ( McQuade et al., 2020 ; Andreone et al., 2020 ; Cosker et al., 2021 ; Konttinen et al., 2019 ; Piers et al., 2020 ; You et al., 2022 ), Ca 2+ signaling has not yet been extensively profiled in these models.”
Piers, T. M., Cosker, K., Mallach, A., Johnson, G. T., Guerreiro, R., Hardy, J., & Pocock, J. M. (2020) · The FASEB Journal · doi:10.1096/fj.201902447r · Cited by 135
Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response
Pimenova, A. A., Herbinet, M., Gupta, I., Machlovi, S. I., Bowles, K. R., Marcora, E., & Goate, A. M. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105217 · Cited by 120 · cited 1×
“…implicated in several neurodevelopmental and neurodegenerative diseases ( Andersen et al., 2021 ; Crotti et al., 2014 ; Fahira et al., 2019 ; Jansen et al., 2019 ; McQuade and Blurton-Jones, 2019 ; Pimenova et al., 2021 ; Tan et al., 2013 ), warranting further study of human microglial dynamics.”
Receptors, Ion Channels, and Signaling Mechanisms Underlying Microglial Dynamics
Madry, C., & Attwell, D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.637157 · Cited by 109 · cited 1×
“ATP released from both homeostatic and damaged cells is hydrolyzed locally by nucleosidases such as the ectonucleotidase NTPDase1 (CD39) or pyrophosphatase NPP1 to produce ADP ( Dissing-Olesen et al., 2014 ; Madry and Attwell, 2015 ; Zhang et al., 2014 ).”
De Simone, R., Niturad, C. E., De Nuccio, C., Ajmone‐Cat, M. A., Visentin, S., & Minghetti, L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06937.x · Cited by 104
Hall-Roberts, H., Agarwal, D., Obst, J., Smith, T. B., Monzón-Sandoval, J., Di Daniel, E., Webber, C., James, W. S., Mead, E., Davis, J. B., et al. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00709-z · Cited by 62
Cited by
Di Benedetto, G., Burgaletto, C., Bellanca, C. M., Munafò, A., Bernardini, R., & Cantarella, G. (2022) · Cells · doi:10.3390/cells11172728 · Cited by 189
“Loss of TREM2 confers a defect in microglial Ca2+ response to purinergic signals, suggesting a window of Ca2+ signalling for optimal microglial motility [145].”
BackgroundMicroglial efferocytosis: Diving into the Alzheimer’s disease gene pool
Romero-Molina, C., Garretti, F., Andrews, S. J., Marcora, E., & Goate, A. M. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.015 · Cited by 111
Microglia, Trem2, and Neurodegeneration
Shi, Q., Gutierrez, R. A., & Bhat, M. A. (2025) · The Neuroscientist · doi:10.1177/10738584241254118 · Cited by 69
“Elevated calcium levels, along with DAG, activate protein kinase C (PKC) and other kinases, facilitating actin cytoskeletal rearrangements essential for phagocytic cup formation and engulfment of targets (Jairaman and others 2022).”
Penney, J., Ralvenius, W. T., Loon, A., Cerit, O., Dileep, V., Milo, B., Pao, P., Woolf, H., & Tsai, L. (2024) · Glia · doi:10.1002/glia.24485 · Cited by 52
Pocock, J., Vasilopoulou, F., Svensson, E., & Cosker, K. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110020 · Cited by 54
Metadata
- Authors
- Jairaman, A., McQuade, A., Granzotto, A., Kang, Y. J., Chadarevian, J. P., Gandhi, S., Parker, I., Smith, I., Cho, H., Sensi, S. L., Othy, S., Blurton-Jones, M., & Cahalan, M. D.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2022-02-22
- Volume
- 11
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W4221108952
- Cited by
- 61
- References
- 38
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.